Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. ReNeuron Group plc
  6. News
  7. Summary
    RENE   GB00BF5G6K95

RENEURON GROUP PLC

(RENE)
  Report
Delayed Quote. Delayed London Stock Exchange - 09/27 11:58:15 am
93.946 GBX   +1.62%
08/11RENEURON : Annual Report 2021
PU
08/06London Shares Fall as Investors Await US Jobs Data
DJ
08/06FTSE 100 Edges Lower, BOE Points to Gradual Tightening, Will Lift Pound
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

ReNeuron Group plc Announces Appointment of Barbara Staehelin as Senior Independent Non-Executive Director

07/14/2021 | 02:00am EDT

ReNeuron Group plc announced that Barbara Staehelin has joined the Board as senior independent Non-Executive Director with immediate effect. Ms. Staehelin's career in the international life sciences and technology sectors spans over 30 years and includes consulting, CEO and Chair roles. She has led and co-founded four life science companies and is currently on the Board as President of the Audit and Risk Committee and a member of the Investment Committee at Assura Group, which operates in the health insurance sector and which is headquartered in Switzerland. Ms. Staehelin's background is in biochemistry and until 2006, she was a member of the Global Executive Committee of Roche Diagnostics.


ę S&P Capital IQ 2021
All news about RENEURON GROUP PLC
08/11RENEURON : Annual Report 2021
PU
08/06London Shares Fall as Investors Await US Jobs Data
DJ
08/06FTSE 100 Edges Lower, BOE Points to Gradual Tightening, Will Lift Pound
DJ
08/06RENEURON : To Appoint New CFO In October
MT
08/06ReNeuron Group plc Appoints Catherine Isted as Chief Financial Officer Effective 11 Oct..
CI
07/14ReNeuron Group plc Announces Appointment of Barbara Staehelin as Senior Independent Non..
CI
07/09RENEURON : Preliminary results presentation for the year ended 31 March 2021
PU
07/08RENEURON : Preliminary Results for the year ended 31 March 2021
PU
07/08RENEURON : Earnings Flash (RENE.L) RENEURON GROUP Posts FY21 Loss GBX-29.00
MT
07/08RENEURON : Earnings Flash (RENE.L) RENEURON GROUP Posts FY21 Revenue GBP257,000
MT
More news
Financials
Sales 2022 0,18 M 0,24 M 0,24 M
Net income 2022 - - -
Net cash 2022 9,53 M 13,1 M 13,1 M
P/E ratio 2022 -
Yield 2022 -
Capitalization 53,0 M 72,6 M 72,6 M
EV / Sales 2022 248x
EV / Sales 2023 85,3x
Nbr of Employees -
Free-Float 72,9%
Chart RENEURON GROUP PLC
Duration : Period :
ReNeuron Group plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RENEURON GROUP PLC
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 93,00 GBX
Average target price 248,12 GBX
Spread / Average Target 167%
EPS Revisions
Managers and Directors
Olav Helleb° Chief Executive Officer & Executive Director
Iain Gladstone Ross Non-Executive Chairman
Richard L. Beckman Chief Medical Officer
Stefano Pluchino Chief Scientific Officer
Suzanne Hancock Head-Operations
Sector and Competitors
1st jan.Capi. (M$)
RENEURON GROUP PLC12.73%73
MODERNA, INC.291.35%173 624
LONZA GROUP AG30.56%59 611
IQVIA HOLDINGS INC.38.49%50 128
CELLTRION, INC.-25.49%31 745
SEAGEN INC.-7.21%29 353